Table 2 List of all pathways where Sens-alus and Ant-alus are enriched or depleted
Pathway | Ant-alu P | Sens-alu P |
|---|---|---|
Ant-alu enriched | Â | Â |
p53 pathway | 0.0005†| 0.2470 |
Opioid prodynorphin pathway | 0.0015†| 0.6090 |
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | 0.0018†| 0.2270 |
Pyridoxal phosphate salvage pathway | 0.0023†| 0.9260 |
Vitamin B6 metabolism | 0.0050†| 0.8910 |
Metabotropic glutamate receptor group II pathway | 0.0070†| 0.5520 |
5HT1 type receptor mediated signaling pathway | 0.0077†| 0.2930 |
Opioid proopiomelanocortin pathway | 0.0088†| 0.4040 |
Opioid proenkephalin pathway | 0.0088†| 0.4040 |
Endogenous_cannabinoid_signaling | 0.0132†| 0.3670 |
GABA-B_receptor_II_signaling | 0.0133†| 0.4560 |
Metabotropic glutamate receptor group III pathway | 0.0144†| 0.5340 |
Muscarinic acetylcholine receptor 1 and 3 signaling pathway | 0.0189†| 0.3270 |
Beta3 adrenergic receptor signaling pathway | 0.0210†| 0.3220 |
Cortocotropin releasing factor receptor signaling pathway | 0.0312 | 0.3770 |
5HT4 type receptor mediated signaling pathway | 0.0341 | 0.1540 |
Synaptic_vesicle_trafficking | 0.0372 | 0.5960 |
p53 pathway feedback loops 2 | 0.0407 | 0.1580 |
Angiotensin II-stimulated signaling through G proteins and beta-arrestin | 0.0438 | 0.5690 |
Ant-alu depleted | Â | Â |
Huntington disease | 0.0230 | 0.3950 |
Sens-alu enriched | Â | Â |
Toll receptor signaling pathway | 0.6120 | 0.0042 |
DPP_signaling_pathway | 0.5960 | 0.0210 |
Nicotinic acetylcholine receptor signaling pathway | 0.2970 | 0.0225 |
Gamma-aminobutyric acid synthesis | 0.8130 | 0.0229 |
SCW_signaling_pathway | 0.4430 | 0.0289 |
BMP_signaling_pathway-drosophila | 0.4430 | 0.0289 |
Interleukin signaling pathway | 0.5740 | 0.0365 |
Endothelin signaling pathway | 0.3140 | 0.0420 |
DPP-SCW_signaling_pathway | 0.5150 | 0.0487 |